BRPI0411451A - formas de dosagens orais de memantina - Google Patents
formas de dosagens orais de memantinaInfo
- Publication number
- BRPI0411451A BRPI0411451A BRPI0411451-5A BRPI0411451A BRPI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A BR PI0411451 A BRPI0411451 A BR PI0411451A
- Authority
- BR
- Brazil
- Prior art keywords
- memantine
- dosage form
- oral dosage
- dosage forms
- patient
- Prior art date
Links
- BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 title abstract 8
- 229960004640 memantine Drugs 0.000 title abstract 8
- 239000006186 oral dosage form Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 abstract 5
- 239000003814 drug Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"FORMAS DE DOSAGENS ORAIS DE MEMANTINA". A presente invenção refere-se a uma forma de dosagem oral contendo entre 1 mg e 100 mg de memantina, em que a forma de dosagem referida não contém 10 mg de memantina ou 20 mg de memantina, e em que a forma de dosagem referida não é preparada pelo paciente ou por uma pessoa que esteja administrando o fármaco ao paciente que divide a forma de dosagem contendo uma dose maior de memantina. Outro aspecto desta invenção refere-se a produtos farmacêuticos compreendendo as formas de dosagens referidas e métodos para administrar memantina e tratar doença com a forma de dosagem referida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47897903P | 2003-06-16 | 2003-06-16 | |
| PCT/US2004/018506 WO2004112768A1 (en) | 2003-06-16 | 2004-06-10 | Memantine oral dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0411451A true BRPI0411451A (pt) | 2006-07-18 |
Family
ID=33539133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0411451-5A BRPI0411451A (pt) | 2003-06-16 | 2004-06-10 | formas de dosagens orais de memantina |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20040254251A1 (pt) |
| EP (1) | EP1631273A1 (pt) |
| JP (1) | JP2006527774A (pt) |
| KR (1) | KR20060033727A (pt) |
| CN (1) | CN1805737A (pt) |
| AU (1) | AU2004249151A1 (pt) |
| BR (1) | BRPI0411451A (pt) |
| CA (1) | CA2529535A1 (pt) |
| IL (1) | IL172233A0 (pt) |
| MX (1) | MXPA05012810A (pt) |
| NO (1) | NO20055880L (pt) |
| PL (1) | PL378902A1 (pt) |
| RU (1) | RU2006101225A (pt) |
| TW (1) | TW200524639A (pt) |
| WO (1) | WO2004112768A1 (pt) |
| ZA (1) | ZA200509379B (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7086532B2 (en) * | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
| FR2855344A1 (fr) * | 2003-05-22 | 2004-11-26 | France Telecom | Systeme de gestion de contexte pour un reseau comportant un ensemble heterogene de terminaux |
| BRPI0512263A (pt) * | 2004-06-17 | 2008-02-26 | Merz Pharma Gmbh & Co Kgaa | formulações de liberação imediata de formas de dosagem oral de memantina |
| US20060002999A1 (en) * | 2004-06-17 | 2006-01-05 | Forest Laboratories, Inc. | Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| AU2005309601A1 (en) * | 2004-11-23 | 2006-06-01 | Neuromolecular Pharmaceuticals, Inc. | Composition comprising a sustained release coating or matrix and an NMDA receptor antagonist, method for administration such NMDA antagonist to a subject |
| US8058291B2 (en) | 2005-04-06 | 2011-11-15 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of CNS-related conditions |
| US20060159753A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Matrix type sustained-release preparation containing basic drug or salt thereof |
| US20060160852A1 (en) * | 2004-12-27 | 2006-07-20 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| CA2592605C (en) | 2004-12-27 | 2010-12-07 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| CA2604617C (en) * | 2005-04-28 | 2014-06-17 | Eisai R&D Management Co., Ltd. | Composition containing anti-dementia drug |
| DE602007003697D1 (de) * | 2006-02-10 | 2010-01-21 | Janssen Pharmaceutica Nv | Ffner |
| AU2007241809A1 (en) * | 2006-04-20 | 2007-11-01 | Itoham Foods Inc. | Pharmaceutical composition for conformational disease |
| CN101528202A (zh) * | 2006-07-05 | 2009-09-09 | 特瓦制药工业有限公司 | 美金刚的药物组合物 |
| EP1908748A1 (en) * | 2006-10-05 | 2008-04-09 | Krka | Process for the preparation of memantine and its hydrochloric acid salt form |
| EP2420235A1 (en) * | 2006-10-27 | 2012-02-22 | Medivation Neurology, Inc. | Methods and combination therapies for treating alzheimer's disease |
| US20080182908A1 (en) * | 2007-01-25 | 2008-07-31 | Vinita Umashankar Vyas | Pharmaceutical compositions comprising memantine |
| EP2170310A4 (en) * | 2007-06-29 | 2010-06-23 | Orchid Chemicals & Pharm Ltd | FAST-DISSOLVING COMPOSITIONS OF MEMANTINE HYDROCHLORIDE |
| EP2583669A1 (en) | 2007-10-10 | 2013-04-24 | Rubicon Research Private Limited | Taste-masked orally disintegrating tablets of memantine hydrochloride |
| WO2009091932A2 (en) * | 2008-01-18 | 2009-07-23 | Adamas Pharmaceuticals, Inc. | Treatment of mild dementia of the alzheimer's disease type |
| US20090247644A1 (en) * | 2008-03-28 | 2009-10-01 | Forest Laboratories Holdings Limited | Memantine formulations |
| JP5885668B2 (ja) | 2009-12-02 | 2016-03-15 | アダマス ファーマシューティカルズ， インコーポレイテッド | アマンタジン組成物および使用方法 |
| IN2014MN02029A (pt) * | 2012-04-24 | 2015-08-14 | Daiichi Sankyo Companyltd | |
| WO2014204933A1 (en) | 2013-06-17 | 2014-12-24 | Adamas Pharmaceuticals, Inc. | Amantadine compositions and methods of use |
| KR20190076711A (ko) | 2017-12-22 | 2019-07-02 | 한미약품 주식회사 | 메만틴을 포함하는 속방성 및 서방성을 동시에 가지는 경질캡슐 제제 및 그 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2856393C2 (de) * | 1978-12-27 | 1983-04-28 | Merz + Co GmbH & Co, 6000 Frankfurt | Arzneimittel zur Behandlung von Morbus Parkinson |
| AUPN605795A0 (en) * | 1995-10-19 | 1995-11-09 | F.H. Faulding & Co. Limited | Analgesic pharmaceutical composition |
| US6057373A (en) * | 1997-05-22 | 2000-05-02 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists |
| US6849271B2 (en) * | 2001-04-27 | 2005-02-01 | Verion, Inc. | Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods |
-
2004
- 2004-06-10 BR BRPI0411451-5A patent/BRPI0411451A/pt not_active IP Right Cessation
- 2004-06-10 WO PCT/US2004/018506 patent/WO2004112768A1/en not_active Ceased
- 2004-06-10 PL PL378902A patent/PL378902A1/pl not_active Application Discontinuation
- 2004-06-10 AU AU2004249151A patent/AU2004249151A1/en not_active Abandoned
- 2004-06-10 CN CNA2004800167729A patent/CN1805737A/zh active Pending
- 2004-06-10 JP JP2006517215A patent/JP2006527774A/ja active Pending
- 2004-06-10 CA CA002529535A patent/CA2529535A1/en not_active Abandoned
- 2004-06-10 EP EP04754939A patent/EP1631273A1/en not_active Withdrawn
- 2004-06-10 KR KR1020057024218A patent/KR20060033727A/ko not_active Withdrawn
- 2004-06-10 RU RU2006101225/15A patent/RU2006101225A/ru not_active Application Discontinuation
- 2004-06-10 MX MXPA05012810A patent/MXPA05012810A/es not_active Application Discontinuation
- 2004-06-15 US US10/869,169 patent/US20040254251A1/en not_active Abandoned
- 2004-06-16 TW TW093117335A patent/TW200524639A/zh unknown
-
2005
- 2005-11-17 ZA ZA200509379A patent/ZA200509379B/xx unknown
- 2005-11-28 IL IL172233A patent/IL172233A0/en unknown
- 2005-12-12 NO NO20055880A patent/NO20055880L/no not_active Application Discontinuation
-
2006
- 2006-07-13 US US11/457,182 patent/US20060251717A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2529535A1 (en) | 2004-12-29 |
| US20040254251A1 (en) | 2004-12-16 |
| RU2006101225A (ru) | 2006-06-10 |
| AU2004249151A1 (en) | 2004-12-29 |
| NO20055880L (no) | 2005-12-28 |
| CN1805737A (zh) | 2006-07-19 |
| PL378902A1 (pl) | 2006-05-29 |
| IL172233A0 (en) | 2006-04-10 |
| ZA200509379B (en) | 2006-11-29 |
| EP1631273A1 (en) | 2006-03-08 |
| US20060251717A1 (en) | 2006-11-09 |
| KR20060033727A (ko) | 2006-04-19 |
| MXPA05012810A (es) | 2006-02-13 |
| TW200524639A (en) | 2005-08-01 |
| JP2006527774A (ja) | 2006-12-07 |
| WO2004112768A1 (en) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mercadante et al. | Pharmacological management of cancer pain in the elderly | |
| MXPA05012810A (es) | Formas de dosis oral de memantina. | |
| CY1116041T1 (el) | Μεσα και μεθοδοι για τη θεραπευτικη αγωγη νεοπλασματικων νοσων | |
| BR0316364A (pt) | Combinação de terapia do câncer com um composto anticâncer ativado com gst e uma outra terapia anticâncer | |
| CY1119001T1 (el) | Ενωσεις 1,2,4-οξαδιαζολο βενζοϊκου οξεος και χρηση αυτων για ανευ νοηματος καταστολη και τη θεραπεια ασθενειας | |
| BR0316906A (pt) | administração do capsaicinoides | |
| BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
| KR960700054A (ko) | 파킨슨씨 병 및 파킨슨 증후군의 치료에 리루졸의 이용(application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes) | |
| AR045972A1 (es) | Formulaciones de tramadol de liberacion sostenida con eficacia de 24 horas | |
| HRP20110035T1 (hr) | Memantin za liječenje blage-do-umjerene alzheimer-ove bolesti | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| BR0115162A (pt) | Tratamentos antitumorais eficazes | |
| BRPI0411079A (pt) | composições farmacêuticas compreendendo atorvastatina, fabricadas sem granulação | |
| BRPI0415713A (pt) | mio-inositol hexafosfato para uso tópico | |
| EP1543158A4 (en) | REGULATED APTAMER THERAPEUTICS | |
| ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| RU2008127882A (ru) | Лечение пищевода барретта | |
| BR0009380A (pt) | Tratamento de câncer melhorado comtemozolomida | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| AR041947A1 (es) | Uso de acetil-l-carnitina o de una sal farmaceuticamente aceptable de la misma para la preparacion de un medicamento para prevenir y/o tratar las neuropatias perifericas inducidas por la administracion de un agente anticancer que induce neuropatias perifericas | |
| KR960028907A (ko) | 암환자를 치료하기 위한 세트랄린의 용도 | |
| AR039162A1 (es) | Formulaciones de venlafaxina de liberacion extendida | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |